Updates and Announcements

The Israel Science Foundation (ISF) and JDRF International are pleased to announce the opening of the first submission cycle for the new...

This year’s talks include a wide range of current topics of interest to the community, which include ground-breaking technologies, cell-based and advanced therapeutics, immmunopathology of type 1 diabetes, pathways to beta cell failure, updates from the Networks...

HIRN New Investigator Pilot Award (2018) The Human Islet Research Network (HIRN) announces a program to support a small number of new...

Please click the link(s) below to register! “Immune System Engineering For Targeted Tolerance in Type 1 Diabetes” https://www.niddk.nih.gov/news/events-calendar/Pages/TargetTolerance2017.aspx “Autoantigens Discovery and Characterization...

JDRF and ISPAD (International Society for Pediatric and Adolescent Diabetes) are pleased to announce that four awardees have been selected to receive...

In partnership with JDRF, ISPAD has increased the funding for this competitive fellowship to US$25,000 and expanded from 1 to 4 awards....

JDRF is pleased to announce the 7th Annual symposium on “Frontier in Beta Cell Biology: Molecular Targeting to the Beta Cell” in partnership...

For key dates and more detailed application information, please visit the original opportunity posting here: http://www.usf.edu/business-finance/purchasing/public-bids/bid-documents/17-08-mh-teddy-study-rna.pdf Any questions concerning this Invitation to...

Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (DP3) For more information, please visit the original RFA-16-009 announcement...

Type 1 Diabetes TrialNet Announces a New Funding Opportunity: Mechanistic Analysis of Stored Samples from the TrialNet Oral Insulin Trials For key...